ABSTRACT
Conclusions: Obtaining random sections in the absence of a gross lesion has no significant benefit, and a negative result is likely to provide inaccurate data to the surgeon. Frozen-section analyses are a generally reliable tool to determine "low-risk" pathologic parameters that were evaluated herein when a gross lesion is present.
Most intraoperative pathologic consultations on uteri are performed to inform decision making on endometrial cancer, [1] [2] [3] [4] most of which are of the endometrioid carcinoma (EC) histotype, early stage, and low to intermediate grade. 5 The probability of lymph node metastases in these Upon completion of this activity you will be able to:
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cases is very low. Accordingly, it remains a matter of some controversy whether lymphadenectomy is of therapeutic or survival benefit to patients in this setting, and no randomized, prospective trial has reported a benefit for full lymphadenectomy in otherwise low-risk patients. [6] [7] [8] [9] [10] [11] [12] Contrary to the 1988 recommendations from International Federation of Gynecology and Obstetrics (FIGO) that full lymphadenectomies be performed for patients with endometrial cancer, 13 more contemporary National Comprehensive Cancer Network guidelines emphasize a more individualized approach to the decision, largely based on preoperatively and intraoperatively obtained clinical and pathologic data that are meant to identify the subset of patients who are not a "low risk" for lymph node metastases. 14, 15 Although definitions for "low risk" differ, Mayo clinic criteria or slight variations thereof are generally accepted as defining "low-risk" cancers, including tumors that are grade 1 or 2, of the EC subtype, and with less than 50% myometrial invasion (MI). 6 In most centers, patients with "low-risk" endometrial cancers will not receive extensive surgical staging, 16 although practice patterns among gynecologic oncologists are somewhat variable. 17 Increasingly, preoperatively determinable parameters, such as those obtainable from the biopsy specimen, serum CA-125, and imaging modalities such as magnetic resonance imaging, are being used to categorize patients into risk groups. [18] [19] [20] [21] However, intraoperative pathologic consultation (IOC) remains the primary approach for optimally segregating the high-risk subset of patients with endometrial cancer who likely require a lymphadenectomy in many centers. Pathologic factors that are potentially determinable during an IOC and that may potentially affect the decision to perform a limited or extensive lymphadenectomy or withhold the procedure include tumor histotype, tumor grade, presence and depth of MI, lymphovascular invasion, and adnexal and cervical involvement. [1] [2] [3] [4] [22] [23] [24] [25] [26] [27] In the current study, we assessed several aspects of the IOC for hysterectomy specimens. First, we compared the pathologic diagnoses that were rendered during IOC regarding tumor histotype/diagnosis, tumor grade, and MI with those that were ultimately rendered as the final diagnosis on permanent sections to determine how reliable an IOC is in accurately determining these "low-risk"-defining pathologic factors. We analyzed specific aspects of the IOC procedure, including the diagnostic value of "gross examination" of the uterus only or obtaining random sections when a gross lesion is not apparent.
Materials and Methods
This is a retrospective multi-institutional study of academic centers located at different geographic regions of the United States. After approval of our institutional review boards, the laboratory information systems at Vanderbilt University Medical Center (VUMC), University of California at San Diego (UCSD), and Ohio State University (OSU) were queried for hysterectomy surgical pathology specimens that underwent an IOC for the study period (2014) (2015) . Preoperative imaging studies have not been analyzed in the current study. Frozensection examination (FSE) data included histologic type, tumor grade (three-tier grading system was used for EC while serous carcinoma, clear cell carcinoma, and carcinosarcoma were considered grade 3), MI, and cervical or adnexal involvement. The final diagnosis data, including pathologic diagnosis, tumor grade, and MI, were analyzed and correlated with the IOC data. If surgical staging by lymphadenectomy was ultimately performed, pathologic findings for these specimens were also documented. Of note, sentinel lymph node sampling for endometrial carcinomas is not a common practice at the three contributing institutions. The practice among gynecologic surgeons is similar at the three institutions: grade 2 tumors are among the high-risk group and considered for surgical staging by lymphadenectomy, although the decision is often personalized for each patient. Therefore, low-risk tumors considered in this study were those tumors of EC histotype and of low grade (G1) with less than 50% MI, and all others were considered highrisk tumors. FSE on the study cases was performed by numerous pathologists at varying levels of professional experience, only a subset of whom are subspecialized in gynecologic pathology.
Gross pathologic examination of hysterectomy specimens was broadly similar at all three institutions. Surgeons may rarely decide to open the uteri in the operating room for gross evaluation, or they may palpate lymph nodes to assess the potential for gross pathology as reported by Plaxe et al. 28 When the hysterectomy specimen is received for IOC, the specimen is typically inspected, measured, weighed, and then bivalved longitudinally through the cervical canal and the endometrial cavity. Any ulcerative, polypoid, poorly defined, hemorrhagic, necrotic, solid, or infiltrative mass(es) in the endometrial cavity are considered "suspicious for malignancy," and sections thereof are taken. The uterine corpus is usually sectioned horizontally at around 5-mm intervals from the endometrial side toward the serosa. The tumor size, site, depth of MI, and thickness of the myometrium are documented. At least one full-thickness section from the area with grossly deepest MI by tumor is submitted for FSE. One or two slides with tissue sections are prepared and stained with a rapid H&E stain for microscopic examination. If gross lesions are not identified, a random section is submitted for FSE, although occasional cases without a grossly visible lesion are subjected only to gross examination.
Statistics
Cohen's unweighted κ statistic was used to assess the agreement between IOC and final interpretation with 95% confidence intervals (CIs). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for IOC regarding diagnosing malignancy, MI, and tumor grade were calculated where the interpretations on the final diagnoses were considered the gold standard. The χ 2 test to compare the accuracy of FSE in determining MI according to the tumor grade was used. The data analysis was generated using the free webpage at http://vassarstats.net/kappa.html.
Results
IOC has not been requested on all hysterectomy specimens, and multiple factors (eg, endometrial biopsy results, imaging studies) influence the decision of the surgeon to request an IOC on a particular case. A request for an IOC on a hysterectomy specimen was received for 99, 56, and 50 (n = 205) cases at VUMC, OSU, and UCSD, respectively. IOC was performed by gross examination only in 17 (8%) of 205 cases, random section in the absence of a gross lesion in 64 (31%) of 205, and microscopic FSE in 124 (60%) of 205. The final diagnoses on permanent section examination of all cases (n = 205) were malignant neoplasm in 136 (66%) and benign/hyperplasia in 69 (34%). In total, 146 (71%) of 205 had a preoperative biopsy/curettage diagnosis with available results (data not analyzed in the current report).
IOC by Gross Examination Only
Of the 17 cases evaluated by gross examination only, a gross lesion suspicious for carcinoma was identified in four and no gross lesion suspicious for carcinoma in 13 cases. Of the four cases with a lesion suspicious for carcinoma, MI was reported as negative or less than 50% in two cases and 50% or more in the other two cases during the IOC with 100% concordance with the MI rendered on final examination. Of the 13 of 17 cases with no gross lesion suspicious for carcinoma on gross examination, two (15%) cases proved to be endometrioid carcinoma, FIGO grade 1 with no or less than 50% MI on the final interpretation. The previous biopsy data on the 13 cases were as follows: seven cases with no biopsy performed/ results not available, three cases with complex atypical hyperplasia, and three cases with EC (one case with no residual carcinoma on the hysterectomy specimen). The specificity and NPV of gross examination only in diagnosing EC in the absence of a gross lesion suspicious for carcinoma were 100% and 85%, respectively.
IOC by Random Frozen-Section Examination in the Absence of a Gross Lesion
❚Table 1❚ summarizes the FSE relative to the final diagnoses in those cases in which no lesion suspicious for malignancy was identified on gross examination (n = 64). Only three (15%) of 20 cases with a final diagnosis of carcinoma had been identified on the random section(s) examined during the IOC. One of the three cases was interpreted intraoperatively as adenocarcinoma not otherwise specified and the others as FIGO 1 EC. On final examination, one (5%) of 20 was diagnosed as a serous carcinoma and 19 (95%) of 20 as EC FIGO grade 1. All of the latter 19 EC cases had no or less than 50% MI on final examination.
The random section submitted during the IOC had a potentially adverse effect in one case by depleting the minimal carcinoma in which the IOC was interpreted as atypical cells present. Reexamination of the IOC slides of this case revealed a multifocal tumor suspicious for superficial invasion. Minimal FIGO 1 EC (2.2 mm) invading 7% of the myometrium was identified on the permanent sections submitted from the rest of the endo-myometrium of this case. The sensitivity, specificity, and NPV of examining random section(s) in the absence of a gross lesion suspicious for malignancy were 15%, 100%, and 72%, respectively.
IOC by Frozen-Section Examination in the Presence of a Gross Lesion
❚Table 2❚ summarizes the FSE according to the final diagnosis in cases with a lesion suspicious for malignancy identified on gross examination (n = 124). Of 112 cases with a malignant diagnosis on final examination, 106 (95%) were interpreted as malignant tumors on section(s) 
Tumor Grade on Frozen-Section Examination and Final Diagnosis
❚Table 3❚ summarizes the correlation between tumor grade for cases with a final diagnosis of carcinoma according to tumor grade interpretation during the IOC for cases in which FSE was performed. Only 60% (64/106) of tumors were graded on FSE. Twenty cases with a final diagnosis of carcinoma were interpreted as benign, hyperplasia, or "no carcinoma" on FSE. The concordance rate in grading endometrial carcinomas between FSE (in the subset on which grade was rendered, n = 64) and the final tumor grade was 72% (κ = 0.81; 95% CI, 0.31-0.70). When combining grades 2 and 3 together against grade 1, the concordance rate improved to 80% (κ = 0.78; 95% CI, 0.39-0.79). With the final grade as the gold standard, three (9%) of 34 were upgraded from grade 1 to grade 2 or 3 on FSE. In contrast, 10 (33%) of 30 were downgraded to grade 1 on FSE (Table 3) .
The sensitivity, specificity, PPV, and NPV of determining grade 1 tumors (to avoid lymphadenectomy) vs grade 2 or 3 by FSE were 91%, 67%, 76%, and 87%, respectively.
MI on Frozen-Section Examination and Final Diagnosis
❚Table 4❚ summarizes the correlation between MI for cases with a final diagnosis of carcinoma according to MI interpretation during the IOC for cases in which FSE was performed. The rate of evaluating MI on FSE was 102 (95%) of 107. Twenty-three cases with a final diagnosis of carcinoma were interpreted as benign/hyperplasia or no carcinoma present on FSE. The concordance rate in evaluating MI between FSE (in the subset where MI was evaluated, n = 102) and the final evaluation of MI was 89% (κ = 0.80; 95% CI, 0.50-0.86).
With the final interpretation of MI as the gold standard, two (3%) of 77 with a final interpretation of less than 50% MI were interpreted as 50% or more MI on FSE. In one of those two cases, a grade 3 diagnosis was rendered on FSE and the patient was surgically staged. No tumor grade was given on FSE for the other case, which was ultimately classified as grade 2 on final diagnosis and was surgically staged based on FSE interpretation. In contrast, nine (36%) of 25 with a final interpretation of 50% or more MI were interpreted as less than 50% MI on FSE. Of those nine cases, three were graded as 2 (of which two cases underwent lymphadenectomy), three cases graded as 1 (none of which were surgically staged), and three cases not graded on FSE (all of which were surgically staged).
The sensitivity, specificity, PPV, and NPV of determining 50% or more MI (to do lymphadenectomy) vs negative or less than 50% MI by FSE were 64%, 97%, 89%, and 89%, respectively. tumor grade as the gold standard, 56 (95%) of 59 grade 1 tumors had a concordance rate, with three of three cases having an underestimation of MI from 50% or more to less than 50% (P < .005). In contrast, 36 (81%) of 44 tumors with final tumor grades 1 and 2 showed a concordance rate in determining MI, with six of eight cases with MI underestimation (P < .005).
MI on Frozen-Section Examination in Relation to

High-Risk Factor on Frozen-Section Examination and Final Diagnosis
Grades 2 and 3, 50% or more MI, and unfavorable histology (non-EC histotypes, including serous, clear cell, undifferentiated, carcinosarcoma, and mixed carcinoma) were considered high-risk factors. For analytical purposes, any tumor with at least one of these features was considered to be in the high-risk group and theoretically should have generated a lymphadenectomy. Conversely, for the purposes of current analysis, the low-risk group was defined as tumors of EC histology, grade 1, and with less than 50% MI. ❚Table 6❚ summarizes the correlation between the high-risk group in carcinoma cases on final diagnosis (n = 95) according to high risk factor reported on FSE during the IOC.
Two cases in the low-risk group on final diagnosis were assigned to a high-risk group on FSE due to misclassification of the tumor grade during IOC (sampling issue). Lymphadenectomy was performed on one case and omitted on the other one. Twelve cases of the highrisk group on final diagnosis were classified as low risk on FSE due to misclassification of the tumor grade in seven cases (due to sampling issue), MI in three cases (incorrect interpretation), and both tumor grade and MI in two cases (incorrect interpretation of MI). The final diagnoses on the 12 cases were as follows: mixed carcinoma (n = 1), FIGO 1 EC (n = 1), FIGO 2 or 3 EC (n = 8), and serous carcinoma (n = 2). No or less than 50% and 50% or more invasion were identified in 10 and two cases, respectively. The concordance rate between FSE and final diagnosis was 84% (κ = 0.76; 95% CI, 0.53-0.82). The sensitivity, specificity, PPV, and NPV of determining a high-risk factor (to perform lymphadenectomy) by FSE were 70%, 96%, 94%, and 79%, respectively.
Surgical Staging by Lymphadenectomy According to IOC and Final Diagnosis
❚Table 7❚ summarizes how many patients got unnecessary staging and how many did not get staging that they should have received according to the presence or absence of a high-risk factor (unfavorable histology, grade 2 or 3, and/or MI ≥50%) as determined by the IOC and final diagnosis. Surgical staging was performed on 67% (24/36) of cases with the IOC of a high-risk factor. The cause of not performing lymphadenectomy on the 12 (33%) of 36 cases was unknown. Approximately one-third (29%) of cases with high-risk factor on both IOC and final diagnosis were not surgically staged. All findings are comparable in the three participating institutions (details are not provided for each institution).
Discussion
The status of the pelvic and para-aortic lymph nodes has prognostic and therapeutic implications on patients with endometrial carcinomas. 29 The rate of lymph node metastasis in otherwise low-risk endometrial cancer (small, low grade, favorable histology, and MI <50%) is low, and lymphadenectomy is unlikely to benefit such patients. 6, [30] [31] [32] As such, the lymphadenectomy procedure may fail to justify its associated costs in this subset of patients, both medically and financially. [8] [9] [10] The reverse is true for patients with high risk factors, who may derive both diagnostic and therapeutic benefit from the procedure. 9 In the current study, we assessed the correlation between IOC and final diagnosis interpretations regarding pathologic diagnosis, tumor grade, and MI. Tumor size, which was variably included in previous analyses of this type, 24 was excluded because the pathologists at the three contributing institutions do not report tumor size consistently on IOC. We assessed the accuracy of a solely macroscopic examination of the uterus during IOC in identifying pathologic risk factors. An accurate gross examination in this setting has the potential not only to decrease turnaround time for IOC but also to reduce the costs associated with the procedure. 33, 34 Overall, the rate at which a gross examination only was performed was found to be low (8%). This low rate appears to have been driven by a combination of pathologic practice patterns (to submit a section routinely) and surgeons (who in some instances ask that a section be submitted even in the absence of a grossly identifiable endometrial lesion). The specificity and PPV of gross examination only in diagnosing endometrial cancer were both 100%. In addition, there was a 100% concordance rate between IOC interpretation (by gross examination only) and final interpretation of MI. The reported sensitivity of gross examination only in diagnosing endometrial cancer ranges from 71% to 79%, and the reported specificity ranges from 93% to 96%. [35] [36] [37] In a recent meta-analysis of 35 studies, the sensitivity, specificity, PPV, and NPV of intraoperative gross evaluation for the assessment of MI were 71%, 91%, 8.1%, and 3.2%, respectively. 38 As is true in most areas of surgical pathology practice, the selection of tissue sections for microscopic examination is most effective if they are informed and directed by gross pathologic findings. However, in the endometrium, cancer may be focal and grossly not apparent. We assessed the value of submitting random section(s) of the endo-myometrium for FSE in the absence of any gross lesion suspicious for malignancy. For the first time, to our knowledge, we did find that random sections were highly ineffective in this scenario, with only a 15% detection rate of carcinoma on the random section(s) examined during the IOC. As such, in the remaining 85% that were not assessed with random sections, a cancer was ultimately diagnosed in the final sections that were not captured in the random sections that were assessed intraoperatively. Nineteen (95%) of 20 cases with no gross lesions identified on FSE were ultimately diagnosed on permanent sections as FIGO 1 EC with 50% or less MI, with the 20th case being a serous carcinoma that was missed on the random IOC section. Thus, we conclude that in the absence of a gross lesion, a high-risk carcinoma is unlikely to be present (a 5% probability based on the data above). However, our data do not have a sizable component of serous intraepithelial carcinomas, minimal serous carcinomas, or other small-volume, grossly not apparent cancers that are still "high risk."
Random sections apparently do not contribute to the detection of carcinoma in this setting, and indeed, given their low cancer detection rate, a negative result may provide false data to the surgeon. Rather, we recommend communication between the pathologist and the surgeon, and the potential pitfalls of submitting random sections. Interestingly, the random section submitted during the IOC adversely affected the final diagnosis in one case in which the diagnostic material was almost exhausted in the frozen sections submitted with only minimal tumor left for ancillary studies. On the other hand, the detection rate of malignant disease was 95% in cases with a grossly suspicious lesion identified on gross examination. All cases with FSE of carcinoma had a final diagnosis of carcinoma, and all cases with FSE of benign had a benign final diagnosis. All cases with frozen-section diagnosis of hyperplasia with a final diagnosis of carcinoma were FIGO 1 EC with no MI on the final examination. The sensitivity, specificity, PPV, and NPV of FSE in the presence of a gross lesion were 95%, 100%, 100%, and 67%, respectively. The concordance rate in pathologic diagnosis between FSE in the presence of a gross lesion and the final diagnosis was 91%.
There remains some controversy regarding whether to include grade 2 tumors in the low-or high-risk group. 6, 9, 39 The Mayo Clinic criteria and others include grade 2 tumors among the low-risk group and do not recommend lymphadenectomy. 6, 22, 40 Others consider grade 2 to be a high-risk factor, 16 which is a standard that we applied in 24 The relatively low (72%) concordance rate between FSE and the final tumor grade is likely a reflection of a multitude of factors, including the known lack of reproducibility among pathologists in the grade 1 vs 2 distinction, 41 sampling issues when grade 2 is potentially characterized by a small architecturally solid component, interpretation errors, and/or suboptimal histologic preparations on FSE. However, when combining grades 2 and 3 together against grade 1, the concordance rate improved substantially to 80% with a sensitivity, specificity, PPV, and NPV of determining grade 1 tumors (to avoid lymphadenectomy) of 91%, 67%, 76%, and 87%, respectively.
In contrast to the low rate of reporting tumor grades, the rate of reporting MI was 95% in the current study. Others reported 100% documentation of MI on FSE. 22 When combining no invasion and less than 50% MI together against 50% or more MI, the concordance rate in evaluating MI between FSE and final diagnosis was 89%. In comparison to Kumar et al, 22 who reported 1% underestimation of MI by FSE, 36% of cases with a final interpretation of 50% or more MI had been interpreted as less than 50% MI on FSE in the present study. This relatively high discordance might be explained by the variety in experience of the individuals rendering these diagnoses, tumor-related factors such as overestimating depth of MI in adenomyosis-involved cancers, and other factors. The high specificity (97%) of determining 50% or more MI (to do lymphadenectomy) is at the expense of the relatively low sensitivity (64%). Compared with our results, Stephan et al 24 reported 93% sensitivity and 99% specificity for FSE to correctly interpret MI. In a meta-analysis study performed by Alcazar et al, 38 the sensitivity, specificity, PPV, and NPV for IOC by FSE to detect MI were 85%, 97%, 32.3%, and 16%, respectively. Several reports have found that increasing grade is associated with decreasing reliability of IOC in determining the presence or depth of MI. 42, 43 In our study, the accuracy of determining MI by FSE was higher (95%) for grade 1 tumors compared with the 82% accuracy rate in highgrade tumors (grades 2 and 3).
Reporting any of the studied high-risk factors (grade 2 or 3, ≥50% MI, or unfavorable histology) in FSE should theoretically put the patient in a high-risk group, and lymphadenectomy should be performed in our analytic construct. The concordance rate between FSE and final diagnosis was 84%, with a sensitivity and specificity of 70% and 96%, respectively, for identifying at least one high-risk factor that may trigger a lymphadenectomy. On FSE, underestimation (ie, failure to identify the highrisk factor) was significantly more common (30%) than overestimation (ie, falsely identifying the presence of a high-risk factor when it is in fact absent, 4%). Potential contributing factors to this observation include sampling errors, errors in interpretation, and technically suboptimal histologic preparations during the IOC. The question of whether misinterpretation of frozen section by categorizing the patient under the wrong risk group affects disease-free or the overall survival has not been addressed due to the short interval for follow-up in the current study. Senol et al 44 reported 4% overestimation of MI and 13% overestimation in tumor grade between IOC and final diagnosis. However, recurrence-free survival and the overall survival in an average follow-up of 27.5 months were similar among the cases with and without discrepant results between the IOC and the final diagnosis. 44 If the decision to perform a lymphadenectomy is entirely based on pathologic factors that are reported intraoperatively, then our data suggest that significant subsets of surgeons do not strictly adhere to the low-risk paradigm, since 13% of the patients who received a "lowrisk" intraoperative diagnosis were staged, and 33% of patients who received a "high-risk" diagnosis were not staged. Potential contributing factors include interinstitutional and interpractitioner variability on defining intermediate-risk patients and patient-specific clinical factors that are dominant over pathologic factors in significant patient subsets.
In conclusion, in the presence of a gross lesion suspicious for malignancy, a "gross-only" examination is an acceptable approach to identify MI. For general diagnosis, a gross-only approach is insufficiently sensitive. Obtaining random sections in the absence of a gross lesion has no significant benefit, and a negative result is likely to provide potentially inaccurate data to the surgeon. Our data indicate that FSE is a generally reliable tool to determine the three potential "low-risk"-defining pathologic parameters in the presence of a gross lesion. The concordance rate between FSE and final sections in broadly categorizing sections obtained from a gross lesion as malignant vs benign was 95%. The concordance rate on histologic grading between the IOC and the final sections was relatively low at 72% and could be marginally improved to 80% in a two-tiered grading system (grade 1 vs higher grades). The FSE/final diagnosis concordance rate regarding MI (presence and depth) was 89%. However, in general, determining MI was found to be most problematic among the three factors. These factors
